Since the discovery of the presence of fetal DNA in maternal blood, non-invasive fetal sex determination has been the test most widely translated into clinical practice. To date there is no agreement between the different laboratories performing such tests in relation to which is the best protocol. As a consequence there are almost as many protocols as laboratories offering the service, using different methodologies and thus obtaining different diagnostic accuracies. By the end of 2007, after a validation study performed in 316 maternal samples collected between the 5th and 12th week of gestation, the fetal sex determination was incorporated into clinical practice in our Service. The test is performed in the first trimester of pregnancy, and it is offered as part of the genetic counseling process for couples at risk of X-linked disorders. As a general rule and in order to avoid misdiagnosis, two samples at different gestational ages are tested per patient. The analysis is performed by the study of the SRY gene by RT-PCR. Two hundred and twenty six pregnancies have been tested so far in these 5 years. Neither false positives nor false negatives diagnoses have been registered, thus giving a diagnostic accuracy of 100%.
References
[1]
Lo, Y.M.; Corbetta, N.; Chamberlain, P.F.; Rai, V.; Sargent, I.L.; Redman, C.W.; Wainscoat, J.S. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350, 485–487, doi:10.1016/S0140-6736(97)02174-0.
[2]
Johnson, K.L.; Dukes, K.A.; Vidaver, J.; LeShane, E.S.; Ramirez, I.; Weber, W.D.; Bischoff, F.Z.; Hahn, S.; Sharma, A.; Dang, D.X.; et al. Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin. Chem. 2004, 50, 516–521, doi:10.1373/clinchem.2003.024380.
[3]
Ho, S.S.; Damayanti, Z.; Chua, W.Y.; Ng, B.L.; Peh, C.M.; Biswas, A.; Choolani, M. Non-invasive prenatal diagnosis of fetal gender using real-time polymerase chain reaction amplification of SRY in maternal plasma. Ann. Acad. Med. Singap. 2004, 5, S61–S62.
[4]
Tachdjian, G.; Frydman, N.; Audibert, F.; Ray, P.; Kerbrat, V.; Ernault, P.; Frydman, R.; Costa, J.M. Clinical applications of fetal sex determination in maternal blood in a preimplantation genetic diagnosis centre. Hum. Reprod. 2002, 17, 2183–2186, doi:10.1093/humrep/17.8.2183.
[5]
Bustamante-Aragones, A.; Rodriguez de Alba, M.; Gonzalez-Gonzalez, C.; Trujillo-Tiebas, J.; Diego-Alvarez, D.; Vallespin, E.; Plaza, J.; Ayuso, C.; Ramos, C. Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia 2008, 14, 593–598, doi:10.1111/j.1365-2516.2008.01670.x.
[6]
Avent, N.D.; Chitty, L.S. Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat. Diagn. 2006, 26, 598–603, doi:10.1002/pd.1493.
[7]
Finning, K.M.; Chitty, L.S. Non-invasive fetal sex determination: Impact on clinical practice. Semin. Fetal Neonatal Med. 2008, 13, 69–75, doi:10.1016/j.siny.2007.12.007.
[8]
Scheffer, P.G.; van der Schoot, C.E.; Page-Christiaens, G.C.; Bossers, B.; van Erp, F.; de Haas, M. Reliability of fetal sex determination using maternal plasma. Obstet. Gynecol. 2010, 115, 117–126, doi:10.1097/AOG.0b013e3181c3c938.
[9]
Akolekar, R.; Farkas, D.H.; van Agtmael, A.L.; Bombard, A.T.; Nicolaides, K.H. Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation. Prenat. Diagn. 2010, 30, 918–923, doi:10.1002/pd.2582.
[10]
Miura, K.; Higashijima, A.; Shimada, T.; Miura, S.; Yamasaki, K.; Abe, S.; Jo, O.; Kinoshita, A.; Yoshida, A.; Yoshimura, S.; et al. Clinical application of fetal sex determination using cell-free fetal DNA in pregnant carriers of X-linked genetic disorders. J. Hum. Genet. 2011, 56, 296–299, doi:10.1038/jhg.2011.7.
[11]
Hill, M.; Finning, K.; Martin, P.; Hogg, J.; Meaney, C.; Norbury, G.; Daniels, G.; Chitty, L.S. Non-invasive prenatal determination of fetal sex: Translating research into clinical practice. Clin. Genet. 2011, 80, 68–75, doi:10.1111/j.1399-0004.2010.01533.x.
[12]
Lim, J.H.; Park, S.Y.; Kim, S.Y.; Kim, D.J.; Choi, J.E.; Kim, M.H.; Choi, J.S.; Kim, M.Y.; Yang, J.H.; Ryu, H.M. Effective detection of fetal sex using circulating fetal DNA in first-trimester maternal plasma. FASEB J. 2012, 26, 250–258, doi:10.1096/fj.11-191429.
[13]
Fernández-Martínez, F.J.; Galindo, A.; Garcia-Burguillo, A.; Vargas-Gallego, C.; Nogués, N.; Moreno-García, M.; Moreno-Izquierdo, A. Non inavsive fetal sex determination in maternal plasma: A prospective feasibility study. Genet. Med. 2012, 14, 101–106, doi:10.1038/gim.2011.8.
[14]
Kim, S.Y.; Lim, J.H.; Park, S.Y.; Kim, M.Y.; Choi, J.S.; Ryu, H.M. Non-invasive prenatal determination of fetal gender using QF-PCR analysis of cell-free fetal DNA in maternal plasma. Clin. Chim. Acta 2012, 413, 600–604, doi:10.1016/j.cca.2011.12.001.
[15]
Rong, Y.; Gao, J.; Jiang, X.; Zheng, F. Multiplex PCR for 17 Y-chromosome specific short tandem repeats (STR) to enhance the reliability of fetal sex determination in maternal plasma. Int. J. Mol. Sci. 2012, 13, 5972–5981, doi:10.3390/ijms13055972.
[16]
White, H.E.; Dent, C.L.; Hall, V.J.; Crolla, J.A.; Chitty, L.S. Evaluation of a novel assay for detection of the fetal marker RASSF1A: Facilitating improved diagnostic reliability of non-invasive prenatal diagnosis. PLoS One 2012, 7, e45073, doi:10.1371/journal.pone.0045073.
[17]
Aghanoori, M.R.; Vafaei, H.; Kavoshi, H.; Mohamadi, S.; Goodarzi, H.R. Sex determination using 291 free fetal DNA at early gestational ages: A comparison between modified mini-STR genotyping method and real-time PCR. AJOG 2012, 202, e1–e8.
[18]
Kolialexi, A.; Tounta, G.; Apostolou, P.; Vrettou, C.; Papantoniou, N.; Kanavakis, E.; Antsaklis, A.; Mavrou, A. Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012, 161, 34–37, doi:10.1016/j.ejogrb.2011.12.025.
[19]
Devaney, S.A.; Palomaki, G.E.; Scott, J.A.; Bianchi, D.W. Noninvasive fetal sex determination using cell-free fetal DNA: A systematic review and meta-analysis. JAMA 2011, 306, 27–36.
[20]
Galbiati, S.; Smid, M.; Gambini, D.; Ferrari, A.; Restagno, G.; Viora, E.; Campogrande, M.; Bastonero, S.; Pagliano, M.; Calza, S.; et al. Fetal DNA detection in maternal plasma throughout gestation. Hum. Genet. 2005, 117, 243–248.
